EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
36 hedge funds and large institutions have $50.1M invested in ESSA Pharma in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
Holders
36
Holding in Top 10
3
Calls
$157K
Puts
–
Top Buyers
| 1 | +$306K | |
| 2 | +$290K | |
| 3 | +$271K | |
| 4 |
JP Morgan Chase
New York
|
+$260K |
| 5 |
DCM
Deuterium Capital Management
Clearwater,
Florida
|
+$174K |
Top Sellers
| 1 | -$1.99M | |
| 2 | -$597K | |
| 3 | -$324K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$180K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$122K |